Costs of bespoke medicines cut

NHS spending on medicines made up for individual patients is set to fall following legislation allowing price lists to be published.

Manufacturers of 'specials', unlicensed medicines manufactured for individual patients with specific needs, were previously not allowed to publicise availability of products.

Spending on such products has tripled in the past two years, as a result of increased outsourcing of manufacturing and rising delivery costs.

In May, GP exclusively revealed that the DoH is now working with the Pharmaceutical Services Negotiating Committee (PSNC) to amend national reimbursement arrangements. Bringing costs down to 2007 levels would save the NHS £107 million a year.

The PSNC said that changing the law to allow publication of price lists could help address cost issues.

'This change has the potential to ease the current problems pharmacy contractors face in procuring these products by improving pharmacy contractor access to information on both the availability and cost of specials from different suppliers.'

The committee said it is encouraging specials manufacturers to publish price lists where practical. But, it recognised that, because of the bespoke nature of some products, this may not be possible in all cases.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins


Already registered?

Sign in

Follow Us:

Just published

Vaccination tracker

UK COVID-19 vaccination programme tracker

GPs across the UK have led the largest-ever NHS vaccination programme in response...

RCGP chair Professor Martin Marshall

Hand PCNs control of primary care infrastructure funding, says RCGP

CCG funding for primary care infrastructure should be handed to PCNs when the bodies...

Professor Martin Marshall and Talking General Practice logo

Podcast: RCGP chair Professor Martin Marshall

Talking General Practice speaks to RCGP chair Professor Martin Marshall.

Dr Chaand Nagpaul

In-house review not enough to stop 'unjust' GMC referrals, warns BMA

Doctors' leaders have repeated calls for a full independent review of the GMC referral...


How widespread is long COVID in the UK?

Millions of people in the UK are living with long COVID. GPonline looks at the data...

COVID-19 vaccination sign

GP contract for autumn COVID-19 booster campaign due shortly

GP practices in England will be invited shortly to sign up for the COVID-19 autumn...